Recap: CrossFirst Bankshares Q4 Earnings

CrossFirst Bankshares (NASDAQ:CFB) reported its Q4 earnings results on Monday, January 22, 2024 at 04:05 PM. Here’s what…

CrossFirst Bankshares (NASDAQ:CFB) reported its Q4 earnings results on Monday, January 22, 2024 at 04:05 PM.

Here’s what investors need to know about the announcement.

Earnings

CrossFirst Bankshares beat estimated earnings by 8.33%, reporting an EPS of $0.39 versus an estimate of $0.36.

Revenue was up $3.06 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 7.32% increase in the share price the next day.

Here’s a look at CrossFirst Bankshares’s past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate 0.32 0.34 0.31 0.32
EPS Actual 0.37 0.35 0.35 0.36
Revenue Estimate 60.60M 62.14M 61.16M 56.06M
Revenue Actual 61.11M 60.32M 62.64M 58.37M

To track all earnings releases for CrossFirst Bankshares visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Scilex Holding Company Releases Preliminary Unaudited Financial Results For Gross And Net Sales For The Year Ended December 31, 2023; Total Product Gross Sales Were In The Range Of $150M-$155M; Total Product Net Sales Were In The Range Of $46.5M-$52.5M

Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute

SCLX